Skip to content

Sevoflurane-remifentanyl versus propofol-remifentanyl in surgery exceeding 4 hours

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN25537214
Enrollment
100
Registered
2005-11-11
Start date
2002-06-12
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prolonged surgery Surgery

Interventions

Please note that as of 04/08/10 the status of this trial has been updated to "Stopped". The study was closed on 16/01/09 due to difficulties in patient recruitment. The study did not reach sufficient

Sponsors

Addenbrooke's Hospital (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients undergoing surgery over 4 hours.

Exclusion criteria

Exclusion criteria: 1. Allergy to sevoflurane or remifentanyl 2. Patient refusal 3. Morbidly obese 4. American Society of Anesthesiologists (ASA) 3 or higher

Design outcomes

Primary

MeasureTime frame
Haemodynamic stability

Secondary

MeasureTime frame
1. Nausea 2. Vomiting 3. Wake up time

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026